It will grow to $2.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Digital device use and reading distance are linked to changes in choroidal thickness among Tokyo children. The study finds ...

Discover why Type 2 diabetes progression remains undetectable. Learn 8 silent processes that damage your body without warning signs or symptoms.

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

Durham-based Atsena Therapeutics has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for ATSN-201, its gene therapy product for the ...

From preventative screening to specialist surgery, these leading consultants are helping patients take charge of their health ...

In a moment that drew applause and admiration from Ghana’s top business and political leaders, Dr. Michael Ekuoba Gyasi, ...

In addition, the comment by the author that cyclists should be licenced is moot because they can already be charged under the ...